NXEN

Nexien BioPharma (QB) Stock Price

0.081
0.00 (0.0%)
0.081

Low
0.028

52 Week Range

High
0.2585

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Nexien BioPharma Inc (QB) NXEN OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.081 16:00:00
Open Price Low Price High Price Close Price Prev Close
0.081 0.062 0.081 0.081 0.081
Bid Price Ask Price Spread News
0.062 0.11 0.048 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5 2,926 $ 0.081 $ 237 - 0.028 - 0.2585
Last Trade Time Type Quantity Stock Price Currency
14:25:05 82 $ 0.0875 USD

Period:

Draw Mode:

Nexien BioPharma Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.52M 55.77M 11.23M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
2.45k $ - - - -

more financials information »

Nexien BioPharma (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NXEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0750.08460.0620.06736915,1730.0068.0%
1 Month0.090.1460.0620.092741929,833-0.009-10.0%
3 Months0.160.1950.06010.096036931,650-0.079-49.38%
6 Months0.0850.25850.06010.130814231,443-0.004-4.71%
1 Year0.0950.25850.0280.098764536,425-0.014-14.74%
3 Years0.371.480.00850.170531940,704-0.289-78.11%
5 Years1.206.000.00850.190694635,430-1.12-93.25%

Nexien BioPharma (QB) Description

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).


Your Recent History
USOTC
NXEN
Nexien Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.